Robust expression of a bioactive mammalian protein in Chlamydomonas chloroplast |
| |
Authors: | Manuell Andrea L Beligni Maria Verónica Elder John H Siefker David T Tran Miller Weber Annika McDonald Thomas L Mayfield Stephen P |
| |
Affiliation: | The Department of Cell Biology and The Skaggs Institute for Chemical Biology, 10550 N. Torrey Pines Road, La Jolla, CA 92037, USA; The Department of Molecular Biology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, CA 92037, USA; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198, USA |
| |
Abstract: | We have engineered the chloroplast of eukaryotic algae to produce a number of recombinant proteins, including human monoclonal antibodies, but, to date, have achieved expression to only 0.5% of total protein. Here, we show that, by engineering the mammalian coding region of bovine mammary-associated serum amyloid (M-SAA) as a direct replacement for the chloroplast psbA coding region, we can achieve expression of recombinant protein above 5% of total protein. Chloroplast-expressed M-SAA accumulates predominantly as a soluble protein, contains the correct amino terminal sequence and has little or no post-translational modification. M-SAA is found in mammalian colostrum and stimulates the production of mucin in the gut, acting in the prophylaxis of bacterial and viral infections. Chloroplast-expressed and purified M-SAA is able to stimulate mucin production in human gut epithelial cell lines. As Chlamydomonas reinhardtii is an edible alga, production of therapeutic proteins in this organism offers the potential for oral delivery of gut-active proteins, such as M-SAA. |
| |
Keywords: | chloroplast genetic engineering orally available biologics protein therapeutics recombinant protein expression in algae |
本文献已被 PubMed 等数据库收录! |
|